Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma.

Glioblastoma (GBM) is the most aggressive and treatment-resistant primary brain tumor in adults. Conventional therapies offer limited benefit due to the tumor's heterogeneity, invasive nature, and the presence of the blood-brain barrier, which restri…

Preview only. Read the full abstract at the source